Welcome to our dedicated page for Ascend Wellness SEC filings (Ticker: AAWH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings and related disclosures for Ascend Wellness Holdings, Inc. (AWH), associated with the symbol AAWH. As a vertically integrated, multi-state cannabis operator with securities trading on the CSE and OTCQX, AWH furnishes certain information to the SEC, including current reports on Form 8-K that incorporate its earnings press releases and other material updates.
In its SEC filings, AWH reports details on quarterly and annual financial performance, capital structure, and significant corporate events. For example, a Form 8-K dated November 10, 2025, furnishes a press release announcing financial results for the quarter ended September 30, 2025. These filings describe revenue from retail and wholesale channels, gross profit and margin metrics, non-GAAP measures such as Adjusted EBITDA and Adjusted Gross Profit, and information on cash, debt, and Net Debt as defined by the company.
Filings and attached exhibits also outline financing transactions, such as private placements of 12.75% Senior Secured Notes due 2029 and secured mortgage loans backed by real estate in Ohio. Disclosures explain how proceeds are used, the interest rates and maturities of the notes, and how these instruments fit into AWH’s broader refinancing and capital structure plans.
Investors reviewing AWH’s filings can expect to find:
- Current reports on Form 8-K furnishing earnings press releases and other material events.
- Discussion of non-GAAP metrics, with definitions and reconciliations to GAAP measures in attached schedules.
- Information on debt facilities, note offerings, and mortgage financings, including key terms and security.
- Context on share repurchase activity under the company’s normal course issuer bid program.
On Stock Titan, SEC filings for AAWH are paired with AI-powered summaries that highlight key figures, capital structure changes, and operational themes, helping readers quickly interpret long documents. Real-time updates from EDGAR ensure that new 8-Ks and other relevant filings appear promptly, while AI-generated explanations clarify the significance of items such as financing transactions, non-GAAP definitions, and management’s commentary on performance.
Ascend Wellness Holdings, Inc. is asking stockholders to vote at its virtual-only 2026 annual meeting on April 29, 2026. The meeting will be conducted via live audio webcast on the Lumi/Odyssey Virtual AGM platform, with registered holders able to log in and vote online using a unique control number and password “ascend2026.”
Stockholders are being asked to elect six directors – including Executive Chairman Abner Kurtin, Chief Executive Officer Samuel Brill, President Francis Perullo, and independent directors Julie Francis, Scott Swid, and Josh Gold – each to serve until the next annual meeting. They will also vote on ratifying WithumSmith+Brown, PC as independent registered public accounting firm for the year ending December 31, 2026.
The proxy also seeks approval of the amended 2021 Stock Incentive Plan, a 10% rolling equity plan that allows stock options, restricted stock, RSUs, SARs and dividend equivalents for employees, directors and other service providers, and reapproval of any unallocated entitlements. The filing outlines board independence, committee structure, dual‑class voting, non‑GAAP measures such as Adjusted EBITDA, and detailed executive compensation for 2024 and 2025.
Ascend Wellness Holdings, Inc. files its annual report describing a vertically integrated, multi-state cannabis business focused on limited-license, adult-use or near-term adult-use markets. The company operates 47 dispensaries, including 9 partner locations, and six cultivation sites with about 258,000 square feet of total canopy as of December 31, 2025.
Ascend is active or has financial interests in seven states, runs multiple in-house and partner brands, and employed roughly 2,300 people as of early 2026. It also put a $100 million mixed shelf registration in place to enable flexible future securities offerings in the U.S. and Canada.
Ascend Wellness Holdings reported Q4 2025 net revenue of $120.5 million and full-year 2025 revenue of $500.6 million, down from $561.6 million in 2024. The company posted a 2025 net loss of $118.2 million, wider than $85.0 million a year earlier, including a $17.0 million arbitration settlement expense in Q4.
Profitability metrics improved, with 2025 Adjusted EBITDA of $116.9 million and a 23.4% Adjusted EBITDA Margin, slightly above 2024. Cash and cash equivalents were $85.7 million as of December 31, 2025, with Net Debt of $215.8 million. The retail footprint reached 48 locations and a buyback retired about 15.8 million shares at an average $0.32 per share.
Ascend Wellness Holdings, Inc. resolved an arbitration dispute with Green Thumb Industries Inc. and TWD18, LLC stemming from a June 2018 side letter agreement. An arbitrator had issued a net award of approximately $19.7 million in favor of Green Thumb.
The parties then entered into a settlement agreement dated February 11, 2026, under which the matter was fully resolved for a negotiated payment of $17.0 million. Ascend Wellness has paid this amount, the award has been fully satisfied and extinguished, all arbitration claims have been resolved, and the company states it does not expect any material disruption to its ongoing operations.
Ascend Wellness Holdings released preliminary, unaudited results for Q4 and full year 2025, showing net revenue of approximately $120 million for Q4 and $500 million for the year. Q4 Adjusted EBITDA is projected at about $30 million, with a ~25% margin, and full-year Adjusted EBITDA at roughly $117 million, a ~23% margin.
The company reported cash and cash equivalents of about $86 million as of December 31, 2025 and no significant debt maturities until 2029. Management highlighted expansion to 47 retail stores and a broader branded product portfolio. An arbitration award was issued in favor of Green Thumb Industries related to a 2018 side letter; Ascend disagrees and is evaluating its options but states it can satisfy the award while maintaining planned operations and loan covenant compliance. A Q4 and full-year earnings call is scheduled for March 12, 2026 at 5:00 p.m. ET.
Ascend Wellness Holdings, Inc. disclosed an adverse arbitration outcome related to a 2018 side letter with Green Thumb Industries. The arbitrator found that both parties breached the agreement’s purchase obligations and awarded Green Thumb about $22 million in damages and Ascend about $2.3 million, resulting in a net award to Green Thumb of roughly $19.7 million. Ascend disagrees with the decision and is evaluating its options but does not currently expect the award to cause any material disruption to its ongoing operations.
Ascend Wellness Holdings, Inc. has filed a shelf registration covering up to $100,000,000 of securities it may offer and sell from time to time. The company can issue Class A common stock, preferred stock, warrants, debt securities, subscription rights, or units in one or more future offerings, with final terms for each sale to be detailed in a separate prospectus supplement.
Ascend is a vertically integrated multi-state cannabis operator focused on limited-license adult-use markets. As of December 18, 2025, it operates 46 dispensaries, including 8 partner locations, across Illinois, Maryland, Massachusetts, Michigan, New Jersey, Ohio, and Pennsylvania, and runs cultivation facilities in six states with about 258,000 square feet of canopy. Its Class A common stock trades on the CSE under “AAWH.U” and on the OTCQX under “AAWH.”
Ascend Wellness Holdings (AAWH) reported softer results for the quarter ended September 30, 2025. Revenue was $124.7 million, down from $141.6 million a year ago, as both retail and third‑party wholesale sales declined. Gross profit held roughly steady, but operating expenses kept the business near break‑even at the operating line, and interest expense weighed on results. The company posted a net loss of $25.8 million, versus a $28.3 million loss last year.
For the first nine months of 2025, revenue totaled $380.0 million with a net loss of $69.5 million. AAWH ended the quarter with cash of $87.3 million, long‑term debt of $343.7 million, and stockholders’ equity of $2.6 million. Management disclosed indicators raising substantial doubt about going concern, but said this was alleviated by cash on hand and $21.7 million of net cash provided by operating activities year‑to‑date. The company completed several tuck‑in transactions for dispensaries and licenses during 2025. As of November 6, 2025, Class A shares outstanding were 202,269,004, with 65,000 Class B shares.